Literature DB >> 10861207

Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase.

A Montalvetti1, J Peña-Díaz, R Hurtado, L M Ruiz-Pérez, D González-Pacanowska.   

Abstract

In eukaryotes the enzyme 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase catalyses the synthesis of mevalonic acid, a common precursor to all isoprenoid compounds. Here we report the isolation and overexpression of the gene coding for HMG-CoA reductase from Leishmania major. The protein from Leishmania lacks the membrane domain characteristic of eukaryotic cells but exhibits sequence similarity with eukaryotic reductases. Highly purified protein was achieved by ammonium sulphate precipitation followed by chromatography on hydroxyapatite. Kinetic parameters were determined for the protozoan reductase, obtaining K(m) values for the overall reaction of 40.3+/-5.8 microM for (R,S)-HMG-CoA and 81.4+/-5.3 microM for NADPH; V(max) was 33.55+/-1.8 units x mg(-1). Gel-filtration experiments suggested an apparent molecular mass of 184 kDa with subunits of 46 kDa. Finally, in order to achieve a better understanding of the role of this enzyme in trypanosomatids, the effect of possible regulators of isoprenoid biosynthesis in cultured promastigote cells was studied. Neither mevalonic acid nor serum sterols appear to modulate enzyme activity whereas incubation with lovastatin results in significant increases in the amount of reductase protein. Western- and Northern-blot analyses indicate that this activation is apparently performed via post-transcriptional control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861207      PMCID: PMC1221116          DOI: 10.1042/0264-6021:3490027

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  A soluble 3-hydroxy-3-methylglutaryl-CoA reductase in the protozoan Trypanosoma cruzi.

Authors:  J Peña-Díaz; A Montalvetti; A Camacho; C Gallego; L M Ruiz-Perez; D Gonzalez-Pacanowska
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

2.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in hepatoma tissue culture cells by serum lipoproteins.

Authors:  E S Kirsten; J A Watson
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

3.  The sterols of Trypanosoma cruzi and Crithidia fasciculata.

Authors:  E D Korn; T Von Brand; E J Tobie
Journal:  Comp Biochem Physiol       Date:  1969-08-15

4.  Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase expressed in Escherichia coli: production of homogeneous protein.

Authors:  K Frimpong; B G Darnay; V W Rodwell
Journal:  Protein Expr Purif       Date:  1993-08       Impact factor: 1.650

5.  Description of a novel eukaryotic deoxyuridine 5'-triphosphate nucleotidohydrolase in Leishmania major.

Authors:  A Camacho; R Arrebola; J Peña-Diaz; L M Ruiz-Pérez; D González-Pacanowska
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.

Authors:  E S Istvan; M Palnitkar; S K Buchanan; J Deisenhofer
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

7.  3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties.

Authors:  J L Concepcion; D Gonzalez-Pacanowska; J A Urbina
Journal:  Arch Biochem Biophys       Date:  1998-04-01       Impact factor: 4.013

8.  Purification, characterization, and cloning of a eubacterial 3-hydroxy-3-methylglutaryl coenzyme A reductase, a key enzyme involved in biosynthesis of terpenoids.

Authors:  S Takahashi; T Kuzuyama; H Seto
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

9.  Synergism in vitro of lovastatin and miconazole as anti-leishmanial agents.

Authors:  P A Haughan; M L Chance; L J Goad
Journal:  Biochem Pharmacol       Date:  1992-12-01       Impact factor: 5.858

10.  Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei.

Authors:  I Coppens; P Bastin; T Levade; P J Courtoy
Journal:  Mol Biochem Parasitol       Date:  1995-01       Impact factor: 1.759

View more
  12 in total

1.  Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.

Authors:  Bruno Pradines; Marylin Torrentino-Madamet; Albin Fontaine; Maud Henry; Eric Baret; Joel Mosnier; Sébastien Briolant; Thierry Fusai; Christophe Rogier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

2.  Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs.

Authors:  Rina P M Wong; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

3.  Antileishmanial effect of mevastatin is due to interference with sterol metabolism.

Authors:  Neeradi Dinesh; Neelagiri Soumya; Sushma Singh
Journal:  Parasitol Res       Date:  2015-07-18       Impact factor: 2.289

4.  Antileishmanial activity of the terpene nerolidol.

Authors:  Denise C Arruda; Fabio Luiz D'Alexandri; Alejandro M Katzin; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

6.  Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani.

Authors:  Sushma Singh; Neeradi Dinesh; Preet Kamal Kaur; Baigadda Shamiulla
Journal:  Parasitol Res       Date:  2014-04-12       Impact factor: 2.289

7.  Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Authors:  Carmen María Martín-Navarro; Jacob Lorenzo-Morales; Rubén P Machin; Atteneri López-Arencibia; José Manuel García-Castellano; Isabel de Fuentes; Brendan Loftus; Sutherland K Maciver; Basilio Valladares; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

8.  Mitochondrial localization of the mevalonate pathway enzyme 3-Hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae.

Authors:  Javier Peña-Diaz; Andrea Montalvetti; Carmen-Lisset Flores; Aurora Constán; Ramon Hurtado-Guerrero; Wanderley De Souza; Carlos Gancedo; Luis M Ruiz-Perez; Dolores Gonzalez-Pacanowska
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

9.  Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene.

Authors:  Manoj Kathuria; Arindam Bhattacharjee; Koneni V Sashidhara; Suriya Pratap Singh; Kalyan Mitra
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

10.  Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis.

Authors:  Liliana Rojo-Arreola; Thavy Long; Dan Asarnow; Brian M Suzuki; Rahul Singh; Conor R Caffrey
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.